Sandbox:Polio prevention: Difference between revisions

Latest revision as of 16:14, 24 October 2016


Vaccine Type	Serotypes covered	Number of Doses	Vaccination Schedule in Endemic and High Risk Countries†
Vaccine Type	Serotypes covered	Number of Doses	Birth	6 weeks	10 weeks	14 weeks
OPV	Monovalent (Serotype 2) Bivalent (Serotypes 1 & 3)‡ *Trivalent (Serotypes 1, 2, & 3)	3 to 4 doses	✔	✔	✔	✔
IPV	Serotype 1 Serotype 2 *Serotype 3	1 dose				✔
†Countries at high risk for importation and subsequent spread ‡Countries at high risk for importation and subsequent spread

@@ Line 21: / Line 21: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center"| IPV
 | style="padding: 5px 5px; background: #F5F5F5;" align="center"| *Serotype 1 <br> *Serotype 2 <br> *Serotype 3
-| style="padding: 5px 5px; background: #F5F5F5;" align="center"| 4 doses
+| style="padding: 5px 5px; background: #F5F5F5;" align="center"| 1 dose
-| style="padding: 5px 5px; background: #F5F5F5;" align="center"|
 | style="padding: 5px 5px; background: #F5F5F5;" align="center"|
 | style="padding: 5px 5px; background: #F5F5F5;" align="center"|
@@ Line 28: / Line 27: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center"| ✔
 |-
-| † <SMALL><SMALL>Countries at high risk for importation and subsequent spread</SMALL></SMALL>
+| style="padding: 5px 5px; background: #F5F5F5;" colspan="7" | <SMALL><SMALL>†Countries at high risk for importation and subsequent spread</SMALL></SMALL><br>  <SMALL><SMALL> ‡Countries at high risk for importation and subsequent spread</SMALL></SMALL>
-| ‡ <SMALL><SMALL>Countries at high risk for importation and subsequent spread</SMALL></SMALL>
+|-
 |}